Sector Update: Healthcare


Healthcare shares are trading lower in pre-market trade.

Bristol-Myers ( BMY ) reports Q4 EPS of $0.51, better than the analyst consensus of $0.43 per share on Capital IQ. Revenue was $4.4 billion, versus expectations of $4.31 billion.

For 2014, the company confirmed its EPS guidance range of $1.65-$1.80. The Street view is $1.78 per share.

And, Medical products manufacturer Covidien plc ( COV ) said its adjusted diluted EPS for Q1 2014 was $1, topping the Capital IQ consensus by $0.06. Net sales rose 3% year over year to $2.64 billion, in line with analysts' estimate.

For fiscal 2014, net sales are expected to grow 2% to 5% from the previous year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities

Referenced Stocks: BMY , COV

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by